Abstract
The decline in functional performance and restriction of adaptability represents the hallmark of skeletal muscle pathologies. The characteristic loss in muscle mass, coupled with a decrease in strength and force output, has been associated with a selective activation of apoptotic pathways and a general reduction in survival mechanisms. Aging and genetic diseases, such as muscular dystrophies, amyotrophic lateral sclerosis, cancer and AIDS, are characterized by alterations in metabolic and physiological parameters, progressive weakness in specific muscle groups, modulation in muscle-specific transcriptional mechanisms and persistent protein degradation. The inability to regenerate and repair the injured muscle is another serious complication in muscle pathologies. Tissue remodeling is therefore an important physiological process, which allows skeletal muscle to respond to environmental demands and to undergo adaptive changes in cytoarchitecture and protein composition, in response to a variety of stimuli. Alterations in extracellular agonists, receptors, protein kinases, intermediate molecules, transcription factors and tissue-specific gene expression compromise the functionality of skeletal muscle tissue, leading to muscle degeneration. Although considerable information has accumulated regarding the physiopathology of muscle diseases, the associated molecular mechanisms are still poorly understood. In this review, we will discuss the molecular basis of muscle atrophy, wasting and regeneration and the current gene and cell therapeutic approaches to attenuate atrophy and frailty associated with muscle diseases.
Keywords: myogenesis, muscle diseases, muscle wasting, proteolytic systems, muscle regeneration, therapeutic intervention, survival factors, stem cell
Current Genomics
Title: Attenuating Muscle Wasting: Cell and Gene Therapy Approaches
Volume: 4 Issue: 7
Author(s): A. Musaro and N. Rosenthal
Affiliation:
Keywords: myogenesis, muscle diseases, muscle wasting, proteolytic systems, muscle regeneration, therapeutic intervention, survival factors, stem cell
Abstract: The decline in functional performance and restriction of adaptability represents the hallmark of skeletal muscle pathologies. The characteristic loss in muscle mass, coupled with a decrease in strength and force output, has been associated with a selective activation of apoptotic pathways and a general reduction in survival mechanisms. Aging and genetic diseases, such as muscular dystrophies, amyotrophic lateral sclerosis, cancer and AIDS, are characterized by alterations in metabolic and physiological parameters, progressive weakness in specific muscle groups, modulation in muscle-specific transcriptional mechanisms and persistent protein degradation. The inability to regenerate and repair the injured muscle is another serious complication in muscle pathologies. Tissue remodeling is therefore an important physiological process, which allows skeletal muscle to respond to environmental demands and to undergo adaptive changes in cytoarchitecture and protein composition, in response to a variety of stimuli. Alterations in extracellular agonists, receptors, protein kinases, intermediate molecules, transcription factors and tissue-specific gene expression compromise the functionality of skeletal muscle tissue, leading to muscle degeneration. Although considerable information has accumulated regarding the physiopathology of muscle diseases, the associated molecular mechanisms are still poorly understood. In this review, we will discuss the molecular basis of muscle atrophy, wasting and regeneration and the current gene and cell therapeutic approaches to attenuate atrophy and frailty associated with muscle diseases.
Export Options
About this article
Cite this article as:
Musaro A. and Rosenthal N., Attenuating Muscle Wasting: Cell and Gene Therapy Approaches, Current Genomics 2003; 4 (7) . https://dx.doi.org/10.2174/1389202033490222
DOI https://dx.doi.org/10.2174/1389202033490222 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Novel Relationship for Schizophrenia, Bipolar and Major Depressive Disorder Part 6: A Hint from Chromosome 6 High Density Association Screen
Current Molecular Medicine Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer's Disease
Current Neuropharmacology Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants
Current Topics in Medicinal Chemistry Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis
Drug Metabolism Letters Neurotoxicity: The Broad Framework of Electron Transfer, Oxidative Stress and Protection by Antioxidants
Current Medicinal Chemistry - Central Nervous System Agents Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies
Current Pharmaceutical Design Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients
Current Alzheimer Research Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
Current Medicinal Chemistry An Update of the Classical and Novel Methods Used for Measuring Fast Neurotransmitters During Normal and Brain Altered Function
Current Neuropharmacology Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Glitazones, PPAR-γ and Neuroprotection
Mini-Reviews in Medicinal Chemistry MicroRNAs and Physical Activity
MicroRNA Role of Dietary Antioxidants in Neurodegenerative Diseases: Where are We Standing?
Current Pharmaceutical Design Activities of Venom Proteins and Peptides with Possible Therapeutic Applications from Bees and WASPS
Protein & Peptide Letters 5-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Complex and Differential Glial Responses in Alzheimer´s Disease and Ageing
Current Alzheimer Research Patents Relating to the Application of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell and Whole Marrow Transplantation for Neurodegenerative Diseases: A Review
Recent Patents on Regenerative Medicine Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders
Current Pharmaceutical Design